ILMN Shares Outstanding History
Below is a table of the ILMN shares outstanding history going back to 2/5/2010:

Date ILMN Shares Outstanding
2/5/2010120.30M
4/15/2010121.79M
7/15/2010124.29M
10/15/2010125.04M
2/4/2011127.63M
4/15/2011123.13M
7/15/2011124.34M
10/15/2011121.44M
1/31/2012122.33M
4/13/2012123.45M
7/13/2012122.99M
10/12/2012123.38M
1/31/2013124.04M
4/12/2013124.38M
7/10/2013125.12M
10/9/2013126.40M
1/31/2014128.20M
4/11/2014128.40M
7/10/2014139.40M
10/8/2014142.00M
1/30/2015143.80M
4/10/2015144.10M
7/9/2015144.70M
10/8/2015146.40M
2/19/2016147.00M
4/29/2016147.20M
7/22/2016146.60M
10/21/2016146.90M
2/3/2017146.30M
4/21/2017146.00M
7/28/2017146.00M
10/20/2017146.00M
2/9/2018147.00M
4/20/2018147.00M
7/27/2018147.00M
10/19/2018147.00M
2/8/2019147.00M
4/18/2019147.00M
7/26/2019147.00M
10/18/2019147.00M

Also see: ILMN Market Cap History
and ILMN YTD Return
ILMN Historical Shares Outstanding:
+2.09% CAGR
ILMN Historical Shares Outstanding: +2.09% CAGR

Mouse over chart for data details
2/5/2010 ...10/18/2019
Illumina is engaged in sequencing- and array-based solutions for genetic and genomic analysis. Co.'s products and services serve customers in a range of markets, enabling the adoption of genomic solutions in research and clinical settings. Co.'s portfolio of integrated sequencing and microarray systems, consumables, and analysis tools is designed to accelerate and simplify genetic analysis.Co.'s portfolio of sequencing platforms represents a family of systems that are used by customers to perform whole-genome, de novo, exome and ribonucleic acid sequencing, and targeted resequencing of specific gene regions and genes. We show 40 historical shares outstanding datapoints in our coverage of ILMN's shares outstanding history.

Understanding the changing numbers of ILMN shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ILMN versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ILMN by allowing them to research ILMN shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes
Get Free SEC filing alerts for ILMN:
ILMN SEC Filing Email Alerts ServiceExternal link
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Illumina (ILMN) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

IMDZ Shares Outstanding History
IMGN Shares Outstanding History
IMMU Shares Outstanding History
IMMY Shares Outstanding History
IMNP Shares Outstanding History
IMV Shares Outstanding History
INCY Shares Outstanding History
INFI Shares Outstanding History
INGN Shares Outstanding History
INO Shares Outstanding History
More Healthcare companies »

 

ILMN Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2019, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.